☰

Patrick McGowan - Publications

Affiliations: 
Chemistry School of Chemistry, Minneapolis, MN, United States 
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Allison M, Caramés-Méndez P, Hofmann BJ, Pask CM, Phillips RM, Lord RM, McGowan PC. Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands. Organometallics. 42: 1869-1881. PMID 37592952 DOI: 10.1021/acs.organomet.2c00553  0.766
2021 Ghandhi LHD, Bidula S, Pask CM, Lord RM, McGowan PC. Bis(N-picolinamido)cobalt(II) Complexes Display Antifungal Activity toward Candida albicans and Aspergillus fumigatus. Chemmedchem. PMID 34327861 DOI: 10.1002/cmdc.202100159  0.75
2021 Lord RM, Zegke M, Basri AM, Pask CM, McGowan PC. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency. Inorganic Chemistry. 60: 2076-2086. PMID 33463147 DOI: 10.1021/acs.inorgchem.0c03704  0.757
2020 Allison M, Caramés-Méndez P, Pask CM, Phillips RM, Lord RM, McGowan PC. Bis(bipyridine)ruthenium(II) ferrocenyl β-diketonate complexes: exhibiting nanomolar potency against human cancer cell lines. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 33073884 DOI: 10.1002/chem.202004024  0.768
2020 Allison M, Wilson D, Pask CM, McGowan PC, Lord RM. β-diketonate versus β-ketoiminate: the importance of a ferrocenyl moiety on improving the anticancer potency. Chembiochem : a European Journal of Chemical Biology. PMID 32176811 DOI: 10.1002/Cbic.202000028  0.707
2019 Lord RM, McGowan PC. Organometallic Iridium Arene Compounds: The Effects of C-Donor Ligands on Anticancer Activity Chemistry Letters. 48: 916-924. DOI: 10.1246/Cl.190179  0.704
2019 Madzivire CR, Caramés-Méndez P, Pask CM, Phillips RM, Lord RM, McGowan PC. Anticancer, antifungal and antibacterial potential of bis(β-ketoiminato)ruthenium(II) carbonyl complexes Inorganica Chimica Acta. 498: 119025. DOI: 10.1016/J.Ica.2019.119025  0.754
2018 Lord R, Zegke M, Henderson IR, Pask CM, Shepherd HJ, McGowan PC. β-Ketoiminato iridium(III) organometallic complexes: Selective cytotoxicity towards colorectal cancer cells HCT116 p53-/. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 30362193 DOI: 10.1002/Chem.201804901  0.741
2017 Basri AM, Lord RM, Allison SJ, Rodríguez-Bárzano A, Lucas SJ, Janeway FD, Shepherd HJ, Pask CM, Phillips RM, McGowan PC. Bis-Picolinamide ruthenium (III) dihalide complexes: dichloride to diiodide exchange generates single trans isomers with high potency and cancer cell selectivity. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 28225184 DOI: 10.1002/Chem.201605960  0.766
2016 Lord RM, Allison SJ, Rafferty K, Ghandhi L, Pask CM, McGowan PC. Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis. Dalton Transactions (Cambridge, England : 2003). PMID 27417660 DOI: 10.1039/C6Dt01464J  0.756
2016 Lucas SJ, Lord RM, Basri AM, Allison SJ, Phillips RM, Blacker AJ, McGowan PC. Increasing anti-cancer activity with longer tether lengths of group 9 Cp* complexes. Dalton Transactions (Cambridge, England : 2003). 45: 6812-5. PMID 26924272 DOI: 10.1039/C6Dt00186F  0.724
2016 Lord RM, Lord SM, Pask CM, McGowan PC. Structural studies of titanium(IV) picolinamide alkoxide and oxide derivatives Polyhedron. 116: 136-143. DOI: 10.1016/J.Poly.2016.04.017  0.668
2016 Lord RM, Mannion JJ, Crossley BD, Hebden AJ, McMullon MW, Fisher J, Phillips RM, McGowan PC. β-Diketonate Titanium Compounds Exhibiting High In Vitro Activity and Specific DNA Base Binding Chemistryselect. 1: 6598-6605. DOI: 10.1002/SLCT.201601290  0.687
2015 Lord RM, Hebden AJ, Pask CM, Henderson IR, Allison SJ, Shepherd SL, Phillips RM, McGowan PC. Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis. Journal of Medicinal Chemistry. 58: 4940-53. PMID 25906293 DOI: 10.1021/Acs.Jmedchem.5B00455  0.756
2015 Santoro A, Lord RM, Loughrey JJ, McGowan PC, Halcrow MA, Henwood AF, Thomson C, Zysman-Colman E. One-pot synthesis of highly emissive dipyridinium dihydrohelicenes. Chemistry (Weinheim An Der Bergstrasse, Germany). 21: 7035-8. PMID 25808835 DOI: 10.1002/Chem.201406255  0.682
2015 Rodríguez-Bárzano A, Lord RM, Basri AM, Phillips RM, Blacker AJ, McGowan PC. Synthesis and anticancer activity evaluation of η(5)-C5(CH3)4R ruthenium complexes bearing chelating diphosphine ligands. Dalton Transactions (Cambridge, England : 2003). 44: 3265-70. PMID 25597645 DOI: 10.1039/C4Dt02748E  0.736
2014 Lord RM, Mannion JJ, Hebden AJ, Nako AE, Crossley BD, McMullon MW, Janeway FD, Phillips RM, McGowan PC. Mechanistic and cytotoxicity studies of group IV β-diketonate complexes. Chemmedchem. 9: 1136-9. PMID 24782045 DOI: 10.1002/Cmdc.201402019  0.741
2014 Almodares Z, Lucas SJ, Crossley BD, Basri AM, Pask CM, Hebden AJ, Phillips RM, McGowan PC. Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents. Inorganic Chemistry. 53: 727-36. PMID 24397747 DOI: 10.1021/ic401529u  0.437
2013 Rodríguez-Bárzano A, Blacker AJ, McGowan PC. Synthesis and characterisation of tetramethylfulvene complexes of ruthenium. Dalton Transactions (Cambridge, England : 2003). 42: 16669-71. PMID 24132047 DOI: 10.1039/c3dt52747f  0.362
2013 Brabec V, Howson SE, Kaner RA, Lord RM, Malina J, Phillips RM, Abdallah QMA, McGowan PC, Rodger A, Scott P. Metallohelices with activity against cisplatin-resistant cancer cells; Does the mechanism involve DNA binding? Chemical Science. 4: 4407-4416. DOI: 10.1039/C3Sc51731D  0.7
2012 Lucas SJ, Lord RM, Wilson RL, Phillips RM, Sridharan V, McGowan PC. Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Dalton Transactions (Cambridge, England : 2003). 41: 13800-2. PMID 23015068 DOI: 10.1039/C2Dt32104A  0.722
2009 Camm KD, El-Sokkary A, Gott AL, Stockley PG, Belyaeva T, McGowan PC. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents. Dalton Transactions (Cambridge, England : 2003). 10914-25. PMID 20023922 DOI: 10.1039/b918902e  0.337
2009 Van Rijt SH, Hebden AJ, Amaresekera T, Deeth RJ, Clarkson GJ, Parsons S, McGowan PC, Sadler PJ. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes Journal of Medicinal Chemistry. 52: 7753-7764. PMID 19791745 DOI: 10.1021/Jm900731J  0.302
2008 Gott AL, McGowan PC, Podesta TJ. Controlling the binding of dihydrogen using ruthenium complexes containing N-mono-functionalised 1,4,7-triazacyclononane ligand systems. Dalton Transactions (Cambridge, England : 2003). 3729-38. PMID 18615220 DOI: 10.1039/b804572k  0.359
2007 Folshade Mokuolu Q, Kilner CA, McGowan PC, Halcrow MA. Mononuclear and unsymmetric dinuclear complexes of the tripodal ligand 2-hydroxyethyl-bis(2-{pyrid-2-yl}ethyl)amine Inorganica Chimica Acta. 360: 4025-4030. DOI: 10.1016/j.ica.2007.04.046  0.382
2004 Gott AL, McGowan PC, Temple CN. The formation, reactivity and interconversion of novel small eta(1)- and eta(3)-triazacyclononane complexes of rhodium(I) and rhodium(III). Dalton Transactions (Cambridge, England : 2003). 1841-5. PMID 15381989 DOI: 10.1039/B401877J  0.315
1994 Green ML, McGowan PC, Morise X. A study of methylcarboxy-η-cyclopentadienyl derivatives of tungsten Polyhedron. 13: 2971-2977. DOI: 10.1016/S0277-5387(00)83416-6  0.465
Show low-probability matches.